Breast Cancer Trial, By Invitation NCT07465497 Sponsor: Instituto Jalisciense de Cancerologia Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, By Invitation

NCT07465497
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People between 18 and 75 years old.
  • People who have a confirmed breast cancer diagnosis at stages IB through IIIC.
  • People who are scheduled to receive chemotherapy before surgery (called neoadjuvant chemotherapy) as part of their treatment plan.
  • People who show an acceptable level of baseline memory and thinking ability, as measured by a specific set of cognitive tests called the CERAD neuropsychological battery, with no severe cognitive impairment.
  • People who are willing and able to provide written consent to take part and follow all study procedures.
  • People who do not have serious other health conditions that could interfere with the study, such as severe psychiatric disorders or neurological conditions.
  • People who have not used probiotic or prebiotic supplements in the month before joining the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose memory and thinking ability testing (via the CERAD neuropsychological battery) shows significant cognitive impairment or dementia.
  • People with serious other health conditions such as uncontrolled diabetes, severe heart or blood vessel disease, or active infections.
  • People with a history of severe psychiatric disorders that could affect thinking ability or their ability to follow the study procedures.
  • People with neurological conditions such as multiple sclerosis, Parkinson's disease, or other disorders that affect cognitive function.
  • People who are pregnant or currently breastfeeding.
  • People with known allergies to any ingredients in the synbiotics or prebiotics being used in the study.
  • People who the trial team considers to be at risk of not being able to follow the study procedures or attend follow-up appointments (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Instituto Jalisciense de Cancerologia
Registry
ClinicalTrials.gov
Start date
27 February 2026
Est. completion
1 December 2026

Where this trial is recruiting

🇲🇽 Mexico

Primary endpoints

Neuropsychological battery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov